Multimerization of a chimeric anti-CD20 single-chain Fv-Fc fusion protein is mediated through variable domain exchange

被引:44
|
作者
Wu, AM
Tan, GJ
Sherman, MA
Clarke, P
Olafsen, T
Forman, SJ
Raubitschek, AA
机构
[1] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Biol, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Beckman Res Inst, Div Biol, Duarte, CA 91010 USA
[3] City Hope Natl Med Ctr, Dept Radioimmunotherapy, Duarte, CA 91010 USA
[4] City Hope Natl Med Ctr, Div Hematol Bone Marrow Transplantat, Duarte, CA 91010 USA
来源
PROTEIN ENGINEERING | 2001年 / 14卷 / 12期
关键词
chimeric scFv-Fc; hinge; multimerization; scFv linker; variable domain interaction;
D O I
10.1093/protein/14.12.1025
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of single-chain anti-CD20 antibodies was produced by fusing single-chain Fv (scFv) with human IgG1 hinge and Fc regions, designated scFv-Fc. The initial scFv-Fc construct was assembled using an 18 amino acid (aa) linker between the antibody light- and heavy-chain variable regions, with the Cys residue in the upper hinge region (Kabat 233) mutagenized to Ser. Anti-CD20 scFv-Fc retained specific binding to CD20-positive cells and was active in mediating complement-dependent cytolysis. Size-exclusion HPLC analysis revealed that the purified scFv-Fc included multimeric as well as monomeric components. Variant scFv-Fcs were constructed incorporating four different hinges between the scFv and Fc regions, or three different linkers in the scFv domain. All formed multimers, with the highest level of multimerization found in the scFv-Fc with the shortest linker (8 aa). Elimination of an unusual salt bridge between residues L38 and H89 in the V-L-V-H domain interface failed to reduce the formation of higher order forms. Structural analysis of the scFv-Fc constructed with 18 or 8 as linkers by pepsin or papain cleavage suggested the proteins contained a form in which scFv units had cross-paired to form a 'diabody'. Thus, domain exchange or cross-pairing appears to be the basis of the observed multimerization.
引用
收藏
页码:1025 / 1033
页数:9
相关论文
共 50 条
  • [31] A genetically engineered anti-CD45 single-chain antibody-streptavidin fusion protein for pretargeted Radioimmunotherapy of hematologic malignancies
    Lin, YK
    Pagel, LM
    Axworthy, D
    Pantelias, A
    Hedin, N
    Press, OW
    CANCER RESEARCH, 2006, 66 (07) : 3884 - 3892
  • [32] NK cell-mediated anti-leukemia cytotoxicity is enhanced using a NKG2D ligand MICA and anti-CD20 scfv chimeric protein
    Zou, Y.
    Luo, W.
    Luo, Q.
    Zhang, C.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1869 - 1870
  • [33] NK cell-mediated anti-leukemia cytotoxicity is enhanced using a NKG2D ligand MICA and anti-CD20 scfv chimeric protein
    Zou, Yizhou
    Luo, Weiguang
    Guo, Jing
    Luo, Qizhi
    Deng, Mi
    Lu, Zhigang
    Fang, Yi
    Zhang, Cheng Cheng
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 48 (10) : 1750 - 1763
  • [34] Efficient induction of T helper type 1-mediated immune responses in antigen-primed mice by anti-CD3 single-chain Fv/interleukin-18 fusion DNA
    Kim, EJ
    Cho, D
    Kim, TS
    IMMUNOLOGY, 2004, 111 (01) : 27 - 34
  • [35] A DNA adjuvant encoding a fusion protein between anti-CD3 single-chain Fv and AIMP1 enhances T helper type 1 cell-mediated immune responses in antigen-sensitized mice
    Lee, Byeong Cheol
    O'Sullivan, Insug
    Kim, Eugene
    Park, Sang Gyu
    Hwang, Seung Yong
    Cho, Daeho
    Kim, Tae Sung
    IMMUNOLOGY, 2009, 126 (01) : 84 - 91
  • [36] Pro-apoptotic effect of an anti-CD37 scFv-Fc fusion protein, in combination with the anti-CD20 antibody, ofatumumab, on tumour cells from B-cell malignancies
    Smolewski, Piotr
    Robak, Pawel
    Cebula-Obrzut, Barbara
    Misiewicz, Malgorzata
    Medra, Aleksandra
    Majchrzak, Agata
    Witkowska, Magdalena
    Stromatt, Scott
    Robak, Tadeusz
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (15) : 2677 - 2684
  • [37] Anti-CD19 chimeric antigen receptor T cells secreting anti-PD-L1 single-chain variable fragment attenuate PD-L1 mediated T cell inhibition
    Yuti, Pornpimon
    Wutti-in, Yupanun
    Sawasdee, Nunghathai
    Kongkhla, Katesara
    Phanthaphol, Nattaporn
    Choomee, Kornkan
    Chieochansin, Thaweesak
    Panya, Aussara
    Junking, Mutita
    Yenchitsomanus, Pa-thai
    Sujjitjoon, Jatuporn
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113
  • [38] Pro-Apoptotic Effect of An Anti-CD37 Scfv-Fc Fusion Protein, in Combination with the Anti-CD20 Antibody, Ofatumumab, on Tumor Cells From B-Cell Malignancies
    Smolewski, Piotr
    Pawel, Robak
    Cebula-Obrzut, Barbara
    Misiewicz, Malgorzata
    Jeske, Aleksandra
    Majchrzak, Agata
    Stromatt, Scott
    Robak, Tadeusz
    BLOOD, 2011, 118 (21) : 722 - 723
  • [39] Antigen-specific targeting of CD28-mediated T cell co-stimulation using chimeric single-chain antibody variable fragment-CD28 receptors
    AlvarezVallina, L
    Hawkins, RE
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (10) : 2304 - 2309
  • [40] Anti-CD20 single chain variable antibody fragment-apolipoprotein A-I chimera containing nanodisks promote targeted bioactive agent delivery to CD20-positive lymphomas
    Crosby, Natasha M.
    Ghosh, Mistuni
    Su, Betty
    Beckstead, Jennifer A.
    Kamei, Ayako
    Simonsen, Jens B.
    Luo, Bing
    Gordon, Leo I.
    Forte, Trudy M.
    Ryan, Robert O.
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 2015, 93 (04): : 343 - 350